Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
nSpire Pocket Peak peak flow meter standard range
21120000136
|
nSpire Pocket Peak peak flow meter standard range | Peak Flow Meters | Appliances | 321 |
|
Stiripentol 500mg oral powder sachets
0408010AGAAADAD
|
Stiripentol | Stiripentol | Central Nervous System | 321 |
|
Urispas 200 tablets
0704020G0BBABAC
|
Urispas | Flavoxate hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 321 |
|
Armour Thyroid 60mg (1 grain) tablets
0602010Z0BBACAB
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | 320 |
|
Autopen 24 hypodermic insulin inj pen reusable for 3ml cartridge 2 unit dial up / range 2-42 units
21010900598
|
Autopen 24 hypodermic insulin inj pen reusable for 3ml cartridge 2 unit dial up / range 2-42 units | Other Appliances | Appliances | 320 |
|
MediScar silicone gel
20033000090
|
MediScar silicone gel | Wound Management & Other Dressings | Dressings | 320 |
|
Mepradec 10mg gastro-resistant capsules
0103050P0BFAAAF
|
Mepradec | Omeprazole | Gastro-Intestinal System | 320 |
|
Nova 2 two piece ostomy system convex 43mm flange 15-30mm
23940709659
|
Nova 2 two piece ostomy system convex 43mm flange 15-30mm | Two Piece Ostomy Systems | Stoma Appliances | 320 |
|
PolyMem dressing (non-adhesive) 17cm x 19cm rectangular
20030600443
|
PolyMem dressing (non-adhesive) 17cm x 19cm rectangular | Wound Management & Other Dressings | Dressings | 320 |
|
Caphosol mouthrinse
21190000004
|
Caphosol mouthrinse | Oral Film Forming Agents | Appliances | 319 |
|
Exforge 5mg/160mg tablets
0206020Z0BBABAB
|
Exforge | Valsartan/amlodipine | Cardiovascular System | 319 |
|
Keromask finishing powder
130802000BBBBAA
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 319 |
|
Pelican Deo-Mint deodorant
23453454504
|
Pelican Deo-Mint deodorant | Deodorants | Stoma Appliances | 319 |
|
Silver nitrate 75% caustic applicators
1307000Q0AAACAC
|
Silver nitrate | Silver nitrate | Skin | 319 |
|
Zocor 40mg tablets
0212000Y0BBACAD
|
Zocor | Simvastatin | Cardiovascular System | 319 |
|
Codimaz 20mg/ml / 5mg/ml eye drops
1106000ABBFAAAC
|
Codimaz | Dorzolamide and timolol | Eye | 318 |
|
Erythromycin ethyl succinate 500mg/5ml susp sugar free
0501050H0AAANAN
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 318 |
|
Fentanyl 100microgram sublingual tablets sugar free
0407020A0AAAWAW
|
Fentanyl | Fentanyl | Central Nervous System | 318 |
|
Genotropin MiniQuick 600microgram inj pf dispos dev
0605010S0BBAMAW
|
Genotropin | Somatropin | Endocrine System | 318 |
|
Methotrexate 2mg/ml oral solution sugar free
1001030U0AACFCF
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 318 |
|
P-Sure sheath 28mm
22302953056
|
P-Sure sheath 28mm | Incontinence Sheaths | Incontinence Appliances | 318 |
|
Bilxona 30mg modified-release tablets
0601021M0BNAAAM
|
Bilxona | Gliclazide | Endocrine System | 317 |
|
Confidence BE soft convex urostomy bag with cover on both sides, standard 13mm-38mm stone
23965909715
|
Confidence BE soft convex urostomy bag with cover on both sides, standard 13mm-38mm stone | Urostomy Bags | Stoma Appliances | 317 |
|
Fidaxomicin 200mg tablets
0501070ACAAAAAA
|
Fidaxomicin | Fidaxomicin | Infections | 317 |
|
Hyoscine hydrobromide 300micrograms/5ml oral solution
0406000L0AABMBM
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | 317 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.